Rankings
▼
Calendar
ONC Q2 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
Q2 2021 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$150M
+128.5% YoY
Gross Profit
$114M
75.8% margin
Operating Income
-$475M
-316.6% margin
Net Income
-$480M
-320.2% margin
EPS (Diluted)
$-5.20
QoQ Revenue Growth
-75.2%
Cash Flow
Operating Cash Flow
-$420M
Free Cash Flow
-$459M
Stock-Based Comp.
$65M
Balance Sheet
Total Assets
$5.5B
Total Liabilities
$1.9B
Stockholders' Equity
$3.6B
Cash & Equivalents
$1.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$150M
$66M
+128.5%
Gross Profit
$114M
$51M
+121.6%
Operating Income
-$475M
-$359M
-32.3%
Net Income
-$480M
-$335M
-43.3%
← FY 2021
All Quarters
Q3 2021 →